Prelude Therapeutics Incorporated Share Price
PRLDPrelude Therapeutics Incorporated Stock Performance
Open $3.27 | Prev. Close $2.88 | Circuit Range N/A |
Day Range $2.78 - $3.27 | Year Range $0.61 - $4.18 | Volume 11,400 |
Average Traded $2.94 |
Prelude Therapeutics Incorporated Share Price Chart
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
25-Feb-26 | $2.94 | $3.29 | +15.03% |
24-Feb-26 | $3.12 | $2.86 | +3.25% |
23-Feb-26 | $2.83 | $2.77 | -0.54% |
20-Feb-26 | $2.27 | $2.79 | +23.23% |
19-Feb-26 | $2.13 | $2.26 | +5.12% |
18-Feb-26 | $2.10 | $2.15 | +1.18% |
17-Feb-26 | $2.13 | $2.13 | -5.13% |
FAQs on Prelude Therapeutics Incorporated Share Price
Can I buy Prelude Therapeutics Incorporated shares in India?
What is the share price of Prelude Therapeutics Incorporated?
What is the 5 year returns of Prelude Therapeutics Incorporated?
What are the high & low stock price of Prelude Therapeutics Incorporated today?
What is the 52-week high and low of Prelude Therapeutics Incorporated stock?